SYSTEMONE is launching a multi-device version of its digital backbone for medical diagnostics, Aspect, in Tanzania, to help improve TB diagnostics, reduce time to treatment, and eventually track treatment outcomes and efficacy. The project will be executed in collaboration with PATH, and funded by The Stop TB Partnership and UNOPS.
This project accelerates the use of digital tools to help reduce the spread of infectious diseases. SystemOne has connected most of the developing world’s GeneXpert® instruments, which are used to diagnose numerous diseases including HIV, TB, and Covid-19. Now SystemOne is adding connectivity to the Truenat® device, from Molbio, to the diagnostic network in Tanzania. In addition, SystemOne will migrate Tanzania’s digital backbone from a cloud infrastructure to in-country servers, while providing training for local staff to encourage long-term sustainability and security.
‘The health authorities at the National Tuberculosis and Leprosy Program (NTLP) in Tanzania understand how information is critical to assess and manage infectious disease programs,’ said Chris Macek, CEO, SystemOne. ‘Information is at the heart of the diagnostic network, and transmitting information rapidly and purposefully helps patients, clinicians, community health workers and program authorities take the best steps at the right moment to improve the chances of a good outcome.’
Integrating new devices with legacy systems
‘Hosting a local Aspect server will keep us more informed and knowledgeable on technical troubleshooting and maintenance of our in-country medical diagnostic devices,’ said Collins Minja, MoH Information, Communication and Technology Officer from the Tanzania Ministry of Health.
This project was supported through the Stop TB Partnership grants ref: SPGFA2022-06, under the New Tools Project funded by the United States Agency for International Development (USAID).
Founded in Massachusetts in 2012, SystemOne focuses on producing solutions for disease surveillance and response. SystemOne has offices in Northampton, MA and Johannesburg, South Africa. The company’s new disease intelligence software, Aspect®, addresses numerous infectious diseases including Zika, Ebola, HIV, Malaria, Hepatitis C, TB, Covid-19 and more on a host of medical diagnostic devices.